I am a Postdoctoral Scholar in the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology at UCLA. My clinical research focuses on clinical optimization of a novel PSMA-targeted therapeutic agent for men with advanced prostate cancer. Besides that, I am working on developing mathematical models to predict clinical outcome and to use artificial intelligence algorithms for automatic detection of prostate cancer. My overarching goal is to clinically implement a patient-individualized approach for PSMA-targeted radioligand treatment and to evolve molecular PSMA-PET imaging as a quantitative imaging biomarker in prostate cancer. I am currently a co-investigator of several ongoing clinical trials at UCLA that covers the field of PSMA theranostics.